Estey EH - Search Results

1

2-Chlorodeoxyadenosine in the treatment of multiple myeloma.

Dimopoulos MA, Kantarjian HM, Estey EH, Alexanian R. Dimopoulos MA, et al. Among authors: estey eh. Blood. 1992 Sep 15;80(6):1626. Blood. 1992. PMID: 1355673 Free article. No abstract available.

2

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).

Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McCredie KB, Beran M, Koller C, Keating MJ, Hirsch-Ginsberg C, Huh YO, et al. Estey EH, et al. Blood. 1992 Feb 15;79(4):882-7. Blood. 1992. PMID: 1346577 Free article.

3

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia.

Kantarjian HM, Estey EH, O'Brien S, Anaissie E, Beran M, Rios MB, Keating MJ, Gutterman J. Kantarjian HM, et al. Among authors: estey eh. Blood. 1992 Feb 15;79(4):876-81. Blood. 1992. PMID: 1737098 Free article.

4

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor.

Estey EH, Dixon D, Kantarjian HM, Keating MJ, McCredie K, Bodey GP, Kurzrock R, Talpaz M, Freireich EJ, Deisseroth AB, et al. Estey EH, et al. Blood. 1990 May 1;75(9):1766-9. Blood. 1990. PMID: 2184901 Free article.

5

Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.

Estey EH, Thall PF, Pierce S, Cortes J, Beran M, Kantarjian H, Keating MJ, Andreeff M, Freireich E. Estey EH, et al. Blood. 1999 Apr 15;93(8):2478-84. Blood. 1999. PMID: 10194425 Free article. Clinical Trial.

6

Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts.

Estey EH, Thall PF, Cortes JE, Giles FJ, O'Brien S, Pierce SA, Wang X, Kantarjian HM, Beran M. Estey EH, et al. Blood. 2001 Dec 15;98(13):3575-83. doi: 10.1182/blood.v98.13.3575. Blood. 2001. PMID: 11739159 Free article. Clinical Trial.

7

Advances in therapy for hairy cell leukemia. A review.

Jaiyesimi IA, Kantarjian HM, Estey EH. Jaiyesimi IA, et al. Among authors: estey eh. Cancer. 1993 Jul 1;72(1):5-16. doi: 10.1002/1097-0142(19930701)72:1<5::aid-cncr2820720104>3.0.co;2-y. Cancer. 1993. PMID: 7685243 Review.

8

Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia.

Estey EH, Giles FJ, Kantarjian H, O'Brien S, Cortes J, Freireich EJ, Lopez-Berestein G, Keating M. Estey EH, et al. Blood. 1999 Oct 1;94(7):2230-5. Blood. 1999. PMID: 10498593 Free article. Clinical Trial.

9

Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.

Estrov Z, Manna SK, Harris D, Van Q, Estey EH, Kantarjian HM, Talpaz M, Aggarwal BB. Estrov Z, et al. Among authors: estey eh. Blood. 1999 Oct 15;94(8):2844-53. Blood. 1999. PMID: 10515888 Free article.

10

Treatment of poor-prognosis, newly diagnosed acute myelogenous leukemia with high-dose cytosine arabinoside (Ara-C) and rHUGM-CSF.

Estey EH, Kantarjian HM, Beran M, McCredie KB, Keating MJ, Deisseroth A, Gutterman JU. Estey EH, et al. Haematol Blood Transfus. 1990;33:732-6. doi: 10.1007/978-3-642-74643-7_134. Haematol Blood Transfus. 1990. PMID: 2182463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters